Why This Fintech Stock is Having Its Worst Day in 6 Years

Dow Jones
Yesterday

Shares of Enova International sank Tuesday and were on pace for their worst decline in six years after the financial technology company pulled regulatory applications and canceled its proposed acquisition of Grasshopper Bancorp.

Enova International stock fell 25% to $169.15 on Tuesday. If the move holds through the closing bell it would be the worst daily percentage decline since March 18, 2020, according to Dow Jones Market Data.

Investors were selling stock after Enova late Monday said that it had withdrawn applications with the Office of the Comptroller of the Currency and the Board of Governors of the Federal Reserve System related the proposed acquisition of Grasshopper.

Enova, therefore, won't be moving forward with the planned $369 billion acquisition of the digital-first commercial bank.

Enova announced an agreement to acquire Grasshopper in December 2025.

"After a thorough evaluation, we are confident that withdrawing our applications is the best decision for Enova and our shareholders," CEO Steve Cunningham said in a press release.

"Regulators do not have clear standards for nonbanks that want to become banks and that serve customers whose credit needs today are met mostly outside of the banking system," Cunningham added as way of explanation for the decision.

Enova stock has risen 7.6% this year even with the sharp price decline Tuesday. Shares have gained 40% over the past 12 months.

 

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10